International Journal of Multiple Sclerosis and Related Disorders

Aims and Scope

The International Journal of Multiple Sclerosis and Related Disorders (JSC) is a peer-reviewed, open-access online journal that publishes the latest developments in the diagnosis and treatment of multiple sclerosis and other related neurological diseases. The journal provides clinicians, researchers, and industry professionals with cover-to-cover coverage of the latest research from around the world. It is an expertly edited publication that is available for free on the web and for subscription.

JSC aims to provide the most comprehensive and up-to-date information on multiple sclerosis and its related disorders, based on original research and reviews of current developments in the field. The journal focuses on topics related to the basic science and clinical practice of multiple sclerosis, as well as related clinical issues. Specific articles may include clinical and laboratory reports, case studies, reviews of current treatments, and new approaches to the management of multiple sclerosis and its related disorders.

JSC is dedicated to accelerating progress and providing knowledge across the field of multiple sclerosis and related disorders. The journal seeks to provide authoritative data and opinion to the medical and research community, and to share the latest developments in understanding the biology, pathophysiology, and clinical management of multiple sclerosis and its related disorders. JSC welcomes original research and review articles, as well as case reports, editorials, and perspectives from a broad range of fields, including neurology, immunology, biochemistry, genetics, epidemiology, and psychology.

We have included a list of keywords to indicate the scope of the journal. If you have any questions, please do not hesitate to contact us at [email protected]

• Autoimmune disease
• Epidemiology
• Atrophy
• Nootropics
• Diplopia
• Neuroplasticity
• Exacerbation
• Comorbidity
• Microbiome
• Accelerometer
• Neuromyelitis optica
• Virology
• Lymphopenia
• Adrenoleukodystrophy
• Demyelination
• Dysesthesias
• Fingolimod
• Ozanimod
• Brain development
• Causes of multiple sclerosis
• Clinically isolated syndrome
• Neurological assessment
• Types of multiple sclerosis
• Epidemiology and genetics
• Neuroimmunological disorders
• Autoimmune diseases of the central nervous system
• Multiple sclerosis
• Neuroinflammation
• Central nervous system
• Myelin
• Autoimmune diseases
• Immune system dysfunction
• Relapsing-remitting multiple sclerosis
• Primary progressive multiple sclerosis
• Secondary progressive multiple sclerosis
• Progressive-relapsing multiple sclerosis
• Multiple sclerosis diagnosis
• Magnetic resonance imaging
• Lumbar puncture
• Multiple sclerosis symptoms
• Cognitive impairment
• Multiple sclerosis relapses
• Multiple sclerosis treatment
• Disease-modifying therapies
• Interferon beta
• Glatiramer acetate
• Teriflunomide
• Dimethyl fumarate
• Natalizumab
• Alemtuzumab
• Ocrelizumab
• Rituximab
• Cladribine
• Siponimod
• B-cell therapies
• T-cell therapies
• Stem cell therapies
• Multiple sclerosis rehabilitation
• Physical therapy
• Occupational therapy
• Speech therapy
• Cognitive rehabilitation